BIBLIOGRAFIA

1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available from: http://www.goldcopd.org/ (update 2014);
2. Stockley RA. Progression of chronic obstructive pulmonary disease: impact of inflammation, comorbidities and therapeutic intervention. Current Medical Research and Opinion 2009; 25(5):1235-1245;
3. Sethi S et al. Inflammation in COPD: Implications for management. Am J Med. 2012; 125(12):1162-70;
4. Hogg J et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. New EnglJ Med 2004; 350(26):2645-2653;
5. Postma DS, Timens W. Remodeling in Asthma and Chronic Obstructive Pulmonary Disease. Proc Am ThoracSoc 2006; 3:434-439;
6. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012; 379:1341-51;
7. Barnes P. Mediators of Chronic Obstructive Pulmonary Disease. Pharmacological Reviews December 2004; 56(4):515-548;
8. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. EurRespir J 2008; 31:1334-1356;
9. Barnes P. Immunology of asthma and chronic obstructive pulmonary disease. Nature Reviews Immunology 2008; | 8:183-192;
10. Jen R, Rennard S, Sin DD. Effects of inhaled corticosteroids on airway inflammation in chronic obstructive pulmonary disease: a systematic review and meta-analysis. International Journal of COPD 2012:7587-595;
11. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD EurRespir J 2009; 33:1165-1185;
12. Wedzicha JA, Seemungal TAR. COPD exacerbations: defining their cause and prevention. Lancet 2007 Sep 1; 370(9589):786-96.